Side-by-side comparison

Pentadeca Arginate (PDA) vs GHRP-1

Arginate-salt analog of BPC-157 developed for improved injection stability and tissue repair. versus First-generation growth hormone-releasing hexapeptide; precursor to GHRP-2/-6.

Pentadeca Arginate (PDA)

Recovery

Arginate-salt analog of BPC-157 developed for improved injection stability and tissue repair.

Top benefits

  • Tendon and ligament healing
  • Better stability than BPC-157 acetate
  • Anti-inflammatory
Full Pentadeca Arginate (PDA) guide

GHRP-1

Performance

First-generation growth hormone-releasing hexapeptide; precursor to GHRP-2/-6.

Top benefits

  • Stimulates pituitary GH release
  • Synergizes with GHRH analogs
  • Lean mass support
Full GHRP-1 guide
AttributePentadeca Arginate (PDA)GHRP-1
CategoryRecoveryPerformance
Typelinearlinear
Chain length15 aa7 aa
FormulaBPC-157 arginate saltC46H56N12O6
Common dose250-500 mcg100-300 mcg
Frequency1-2x daily SC1-3x daily
Top benefitTendon and ligament healingStimulates pituitary GH release
Top side-effectInjection-site irritationMild cortisol/prolactin rise

Educational use only

This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.